U.S. halts hydroxychloroquine clinical trial after finding no additional benefit for COVID-19 patients

The National Institutes of Health announced Saturday that it has halted a clinical trial evaluating the safety and effectiveness of drug hydroxychloroquine as a treatment for adults hospitalized with COVID-19.